Hyundai Bioscience Co. Ltd

KQ:048410 Korea Biotechnology
Market Cap
$1.02 Billion
₩1.49 Trillion KRW
Market Cap Rank
#7754 Global
#167 in Korea
Share Price
₩15540.00
Change (1 day)
-1.33%
52-Week Range
₩4595.00 - ₩20000.00
All Time High
₩54700.00
Categories
Companies in Korea Biotechnology
About

Hyundai Bioscience Co., Ltd. operates as a biotechnology company. The company provides Vitabrid C12, a vitamin C product that delivers active vitamin C into the skin. It develops Polytaxel, a drug for pancreatic cancer and solid tumors; and CP-COV03 drug for Covid 19. The company was founded in 2000 and is based in Seoul, South Korea.

Hyundai Bioscience Co. Ltd - Asset Resilience Ratio

Latest as of September 2025: 20.53%

Hyundai Bioscience Co. Ltd (048410) has an Asset Resilience Ratio of 20.53% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
₩23.94 Billion
Cash + Short-term Investments
Total Assets
₩116.62 Billion
All company assets
Resilience Assessment
Good
Financial Resilience Level

Asset Resilience Ratio Trend (2002–2023)

This chart shows how Hyundai Bioscience Co. Ltd's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Hyundai Bioscience Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents ₩0.00 0%
Short-term Investments ₩23.94 Billion 20.53%
Total Liquid Assets ₩23.94 Billion 20.53%

Asset Resilience Insights

  • Good Liquidity Position: Hyundai Bioscience Co. Ltd maintains a healthy 20.53% of assets in liquid form.
  • This level provides good financial flexibility while maintaining productive asset deployment.
  • The company has significant short-term investments, indicating active treasury management.

Hyundai Bioscience Co. Ltd Industry Peers by Asset Resilience Ratio

Compare Hyundai Bioscience Co. Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
MedPacto Inc
KQ:235980 		Biotechnology 49.82%
Shenzhen CAU Technology Co Ltd
SHE:000004 		Biotechnology 6.20%
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403 		Biotechnology 6.88%
Nanhua Bio Medicine Co Ltd
SHE:000504 		Biotechnology 11.93%
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518 		Biotechnology 0.03%
Chengzhi Shareholding Co Ltd
SHE:000990 		Biotechnology 6.73%
Hualan Biological EngineeringInc
SHE:002007 		Biotechnology 14.68%
Da An Gene Co Ltd of Sun Yat-Sen University
SHE:002030 		Biotechnology 4.35%

Annual Asset Resilience Ratio for Hyundai Bioscience Co. Ltd (2002–2023)

The table below shows the annual Asset Resilience Ratio data for Hyundai Bioscience Co. Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2023-12-31 18.94% ₩10.00 Billion ₩52.79 Billion -8.88pp
2022-12-31 27.82% ₩18.73 Billion ₩67.33 Billion +0.26pp
2021-12-31 27.57% ₩22.20 Billion ₩80.53 Billion +6.76pp
2020-12-31 20.81% ₩19.21 Billion ₩92.31 Billion +9.65pp
2019-12-31 11.16% ₩7.06 Billion ₩63.24 Billion +5.30pp
2018-12-31 5.85% ₩3.16 Billion ₩54.01 Billion -9.32pp
2017-12-31 15.17% ₩7.51 Billion ₩49.50 Billion -8.69pp
2016-12-31 23.86% ₩12.74 Billion ₩53.38 Billion +21.76pp
2015-12-31 2.10% ₩910.00 Million ₩43.41 Billion -0.68pp
2014-12-31 2.77% ₩910.00 Million ₩32.81 Billion +2.32pp
2013-12-31 0.45% ₩140.09 Million ₩30.84 Billion +0.45pp
2012-12-31 0.00% ₩66.00K ₩32.06 Billion -5.43pp
2011-12-31 5.43% ₩1.65 Billion ₩30.47 Billion +5.11pp
2010-12-31 0.32% ₩154.50 Million ₩48.45 Billion -4.12pp
2009-12-31 4.43% ₩2.71 Billion ₩61.19 Billion +0.43pp
2008-12-31 4.01% ₩3.51 Billion ₩87.53 Billion -13.64pp
2007-12-31 17.65% ₩18.21 Billion ₩103.16 Billion +15.06pp
2006-12-31 2.58% ₩2.73 Billion ₩105.52 Billion -15.58pp
2005-12-31 18.16% ₩41.93 Billion ₩230.83 Billion +3.53pp
2004-12-31 14.64% ₩32.91 Billion ₩224.80 Billion +1.80pp
2003-12-31 12.84% ₩31.14 Billion ₩242.55 Billion -4.91pp
2002-12-31 17.74% ₩35.59 Billion ₩200.60 Billion --
pp = percentage points